The data suggests a consistent growth in the number of scientific publications among the top 10% cited in infectious diseases in the U.S. from 2024 to 2028. Starting from a forecasted figure of 378.02 in 2024, this number is predicted to increase year-on-year, with a marginal growth rate peaking at 382.24 in 2028. Comparatively, between 2023 and 2024, the trend shows a bullish growth pattern, reflecting the U.S.'s ongoing commitment to research in infectious diseases. The compound annual growth rate (CAGR) further highlights a steady rise in publication numbers over the five-year forecast period.
Future trends to watch for include:
- Potential shifts in research funding, which may influence publication volumes
- Evolving global health priorities affecting research scope
- The impact of innovative research technologies and cross-disciplinary collaborations on publication output
